Information about Eureka Pharma
My details
*
*
*

Eureka Pharma (SPRL)

Company information

Status
Active

Enterprise number

BE0877.239.492

VAT liability
Yes
Established
14-11-2005
Last balance sheet year
2024
Company size
Small 6,5 FTE
Principal activity
Wholesale of pharmaceutical and medical goods
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Eureka Pharma

2024 2023 2022 2021
Profit/Loss 45,426 -52 % 95,252 -68 % 293,627 -48 % 565,833
Equity 1,607,946 3 % 1,562,520 6 % 1,467,269 25 % 1,173,641
Gross margin 735,335 2 % 717,989 -6 % 760,527 -50 % 1,523,471
Employees 6.5 5.8 6 7.7

Publications from Eureka Pharma

Date Publication
17-10-2016 Registered Office (NL)
06-03-2014 Resignations - Appointments (NL)
08-07-2010 Registered Office (NL)
30-01-2006 Appointment(s) (NL)
23-11-2005 Constitution (NL)

Frequently asked questions

What is the VAT number of Eureka Pharma?
The VAT number of Eureka Pharma is BE 0877.239.492.
Wat is the PEPPOL ID of Eureka Pharma?
The PEPPOL ID of Eureka Pharma is 0208:0877239492. Log in or start a free trial to see the full overview.
When was Eureka Pharma founded?
Eureka Pharma was founded on 14-11-2005.
What is the address of Eureka Pharma?
The current registered office of Eureka Pharma is located at Harelbeeksestraat 81, 8520 Kuurne.
When was the last time Eureka Pharma filed their annual financial statements?
The most recent financial statements of Eureka Pharma were filed on 03-07-2025.
How many employees does Eureka Pharma have?
There are 6,5 FTEs working at Eureka Pharma according to the staff figures in the most recent financial statements.
What is the annual turnover of Eureka Pharma?
At the time of its most recent financial statements, Eureka Pharma did not publish any turnover figures. Eureka Pharma reported a gross margin of €735,334.63.